ALPS-HN: A Programme Development Grant funded by the NIHR
@alps-hn.bsky.social
We are aiming to develop a skills framework and assessment procedure for SLTs working in the suspected HNC ENT two-week-
wait clinic pathway with patients stratified as being at low-risk of cancer, informed by literature and agreed by expert consensus.
wait clinic pathway with patients stratified as being at low-risk of cancer, informed by literature and agreed by expert consensus.
How will we define 'low-risk'? EVEREST-HN is an NIHR-funded research programme that is aiming to develop a risk stratification tool. Find out more here: www.royalmarsden.nhs.uk/everest-hn
EVEREST-HN | The Royal Marsden
Everest is a research programme aimed at improving the suspected head and neck cancer pathway, speeding up diagnosis, improving the patient experience and optimising the use of healthcare resources.
www.royalmarsden.nhs.uk
November 27, 2024 at 11:57 AM
How will we define 'low-risk'? EVEREST-HN is an NIHR-funded research programme that is aiming to develop a risk stratification tool. Find out more here: www.royalmarsden.nhs.uk/everest-hn